Liabilities / Assets
77th percentile
Higher debt load relative to assets than 77% of similar nonprofits.
Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.
Liabilities / Assets
77th percentile
Higher debt load relative to assets than 77% of similar nonprofits.
Liabilities / Revenue
71st percentile
Higher debt load relative to revenue than 71% of similar nonprofits.
Net Margin
25th percentile
Higher net margin than 25% of similar nonprofits.
Top Officer Pay
Score unavailable
This filing does not contain officer compensation rows.
Asset Growth
18th percentile
Faster asset growth than 18% of similar nonprofits.
Revenue Growth
48th percentile
Faster revenue growth than 48% of similar nonprofits.
Assets
Down$58,817
Down $18,043 (-23%) from 2012
Net Assets
Down$52,027
Down $19,748 (-28%) from 2012
Liabilities
Up$6,790
Up $1,705 (+34%) from 2012
Revenue
Up$259,344
Up $1,147 (+0.4%) from 2012
Expenses
Down$281,370
Down $26,637 (-8.6%) from 2012
Net Income
Up-$22,026
Up $27,784 (+56%) from 2012
This 2013 filing currently has summary financial data only. Detailed schedules, leadership, and program rows are not available for this filing yet.
To provide and facilitate access to objective, accurate, and non-judgmental information about psychoactive plants, chemicals, drugs, technologies, and related issues that affect the mind, body, and culture. Erowid Center supports and trains libraries, publishers, and other information distributors on issues related to our field. Further, it is Erowid Center's goal to support medical, legal, scientific, academic, and independent experts in developing and publishing related resources.
No mirrored PDF or thumbnail assets are attached yet.
Displayed year
2013 • Form 990Summary only. Only limited summary data is available for this year.